- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Biggest Stem Cell Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
VIDEO — Expert: Cannabis Investments Need US Reform in 2022
Dan Ahrens of AdvisorShares spoke to INN about his takeaways from 2021 in the cannabis investment space.
Expert: Cannabis Investments Need US Reform in 2022 youtu.be
As the year wraps up, one of the top cannabis investment experts breaks down his 2021 highlights and the expectations investors should have for 2022.
The Investing News Network (INN) sat down with Dan Ahrens, chief operating officer and portfolio manager with AdvisorShares, to get his perspective on what investors will remember about 2021 and what's next in the space.
Ahrens, an author and manager of two noteworthy cannabis public funds — the AdvisorShares Pure Cannabis ETF (ARCA: YOLO ) and the AdvisorShares Pure US Cannabis ETF (ARCA: MSOS ) — is encouraged by what's ahead.
The industry has gone through a challenging period since the highs seen near the start of the year. According to Ahrens, the possibility of political changes at the federal level in the US initially built momentum. However, that anticipation has instead led to frustration over progress in the country.
Ahrens spoke candidly about the irritation he has felt watching the political path for cannabis in the US after seeing so much excitement for both Joe Biden's presidential win and a critical run-off election at the Senate that gave Democrats an edge in the government chamber.
"Cannabis started with a big run-up in January and February … and things dragged from there," Ahrens said.
As of November 23, both MSOS and YOLO had seen double-digit drops year-to-date in the stock market, with MSOS down nearly 30 percent and YOLO dipping over 16 percent.
The exchange-traded fund manager said investors need to understand that volatility in the cannabis space will continue to be present. "It can drag on for quite awhile and be very painful," he said.
Despite the challenges of the year, Ahrens is encouraged by the maturity displayed by US operators in particular, which in his view are in desperate need of federal reform to elevate into the next phase.
"There's been a big, big separation between company performance, between the actual financials, revenue growth quarter-over-quarter and year-over-year, vs. the stock price," Ahrens told INN.
Watch the full interview above to hear the rest of Ahrens' thoughts on cannabis investments and what's ahead in 2022. You can also click here to watch the rest of the videos on our YouTube channel.
Don't forget to follow us
for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
- Cannabis Weekly Round-Up: Canadian Adult Sales to Reach C$4.8 Billion in 2022 | INN ›
- Cannabis Weekly Round-Up: Canopy Gets Booted from S&P/TSX 60 Index | INN ›
- Cannabis Weekly Round-Up: HEXO Posts C$690.2 Million Quarterly Loss | INN ›
- Could US Cannabis Reform Help the Canadian Market? | INN ›
- Could Germany's Cannabis Actions Create a Domino Effect for Europe? ›
- Cannabis Weekly Round-Up: HEXO Quarterly Loss Reaches C$146.6 Million ›
- Cannabis Weekly Round-Up: US Legalization Push Causes Stock Run ›
- Cannabis Market Update: Q1 2022 in Review ›
- Cannabis Market Update: Q2 2022 in Review ›
- Experts Review Cannabis in H1 2022 ›
- Cannabis Market Update: Q2 2022 in Review ›
- Cannabis Market Update: Q3 2022 in Review ›
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.